|
|
News for Healthier Living
Perioperative Apalutamide in High-Risk Localized or Locally Advanced Prostate Cancer Substudy Supports Reduced Risk of Metastasis and Death
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer with apalutamide -- a next-generation neoadjuvant androgen-receptor pathway inhibitor (ARPI) -- plus hormone therapy before and after prostate cancer surgery, was further validated by a substudy demonstrating a reduced risk of metastasis or death compared with standard of care.
The substudy, co-led by principal investigator Mary-Ellen Taplin, MD, medical oncologist at Dana-Farber Cancer Institute, was presented at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain and published today in European Urology.
October 26, 2026
October 27 2026October 26 2026October 25 2026October 24 2026October 23 2026October 22 2026October 21 2026October 20 2026October 19 2026October 18 2026October 17 2026October 16 2026October 15 2026 - What Genetic Testing After a Miscarriage Can Tell You
- Targeted Radiation Shows Promise for Life-Threatening Kidney Cancer Complication
- Study Finds Common Chemicals May Alter Normal Breast Development
- Newly Identified Functions for Immune Molecule Fights Viruses While Reducing Harmful Inflammation: Study
- Why Exposure to Firearm Suicide May Not Mean Safer Gun Storage
- Large-Scale Study Advances Detection of DNA Mutations Across the Human Genome
- 'What's the Best That Can Happen?' A Sensational Treatment for Breast Cancer
- RWJBarnabas Health Names Dr. Erwin Wang, MD, MHA, SFHM, Senior Vice President of Physician Performance Improvement
- GW Researchers Find Global Distrust Networks Unchanged Despite 6 Years of Moderation and Many Millions Spent
- Researchers Restore Neuron Function in Mice with Alzheimer's Disease
- UT MD Anderson Shares Latest Research Breakthroughs
- Cedars-Sinai Sends New Stem Cell Experiments to Space
- The Plague, Rare but Still Around, Is Both Preventable and Treatable
- Who Gets Alzheimer's Drugs? Race, Vulnerability and Health Status Shape Access
- Ultra-Processed Food Intake Linked to Silent Strokes in Healthy Middle-Aged Adults, Study Finds
- HSS Study Finds Robotic-Assisted Lumbar Fusion Associated with Lower Opioid Use After Surgery
- UCLA Researchers Identify Key Pathway That Drives T-Cell Exhaustion in Cancer Immunotherapy
- Inflammatory breast cancer: Fast-moving form often lacks lump as warning sign
- What's the Latest on 7-OH and Kratom Availability and Addiction Care?
- Clinical Trial to Evaluate Blood Test for Early Detection of Breast Cancer
- Cardiac Surgery Team at Meduni Vienna Finds a Solution to One of the Key Problems in Aortic Valve Treatment
- Skin Has a Sex: Females and Males Do Not Renew Their Skin in the Same Way
- Smoking Alters Reproductive Organs in Both Men and Women, New Study Finds
- Many Older Adults Make Medicare Decisions Quickly & Most Don't Change Plans, Poll Finds
- New Research and Policy Priorities Chart a Broader Role for HEOR
- Pill Shows Promise for Patients With Ulcerative Colitis
- Neurobiologists Trigger Learned Movements by Activating Just 20 Brain Cells
- Study Identifies Brain Pathways Linked to Sustained Improvement in Those Receiving Deep Brain Stimulation for Treatment-Resistant Depression
- Two Types of Recurring Brain Cancer--Radically Different Mutations
- First Cosmic Organoid Villages(tm) Launch to Space Station, Advancing Research Toward 'Clinical Trials in a Dish'
- Online Sports Betting Legalization Linked to Increased Use of Depression and Anxiety Treatment
- PANoptosis emerges as a unified cell-death hub and a promising drug target
- Neighborhood Conditions Linked to Childhood Cancer Survivors' Long-Term Health
- The Medical Minute: 10 Health Tips for Parents During Cold and Flu Season
- Parents of Kids Who Need Complex Medical Care at Home Tend to Resolve Frequent Safety Issues on Their Own, Study Finds
October 14 2026October 13 2026
|
|
|
|
|